Microcirculation in Spontaneous Breathing Trial

December 12, 2022 updated by: National Taiwan University Hospital

Association Between Change of Microcirculation After Spontaneous Breathing Trial and Ventilator Weaning

Weaning ventilator support in critically ill patients is crucial. Both delayed extubation and unexpected early reintubation are harmful to the patients. Weaning parameters and spontaneous breathing trial are used to investigate the indication and predict the successful extubation. Hemodynamic stability and physical reserve are important indicators as well. Microcirculation parameters are known to be more sensitive to the change of hemodynamic status than macrocirculation parameters. We hypothesize that the change of sublingual microcirculation before and after spontaneous breathing trial is different between the the patients with successful extubation and the patients with failed extubation. Thus, this study measures sublingual microcirculation in patients receiving spontaneous breathing trial and record the extubation status (successful or failed). The microcirculation parameters before and after spontaneous breathing trial are compared between the the patients with successful extubation and the patients with failed extubation.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

59

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 10002
        • National Taiwan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Critically ill patients who are ready for weaning ventilator support and receive spontaneous breathing trial.

Description

Inclusion Criteria:

  • critically ill patients received ventilator longer than 12 hours
  • ready for spontaneous breathing trial
  • GCS coma score equal or higher than 8

Exclusion Criteria:

  • aged less than 20 years
  • patient with tracheostomy
  • patient and patients' relatives are non-native speakers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Successful extubation
The patients pass the spontaneous breathing trial and are successful extubated without reintubation within 72 hours. .
Sublingual microcirculation images were recorded using an incident dark-field video microscope
Failed extubation
The patients pass the spontaneous breathing trial and are successful extubated with reintubation within 72 hours. .
Sublingual microcirculation images were recorded using an incident dark-field video microscope

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Initial total vessel density
Time Frame: 0 hour
Total vessel density measured by Cytocam before and after spontaneous breathing trial
0 hour
Change of total vessel density
Time Frame: baseline and 1 hour
The difference between the total vessel density measure by Cytocam before and after spontaneous breathing trial
baseline and 1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Initial perfused vessel density
Time Frame: 0 hour
Perfused vessel density measured by Cytocam before spontaneous breathing trial
0 hour
Change of perfused vessel density
Time Frame: baseline and 1 hour
The difference between the perfused vessel density measure by Cytocam before and after spontaneous breathing trial
baseline and 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 5, 2019

Primary Completion (Actual)

June 13, 2022

Study Completion (Actual)

September 30, 2022

Study Registration Dates

First Submitted

January 13, 2021

First Submitted That Met QC Criteria

January 14, 2021

First Posted (Actual)

January 15, 2021

Study Record Updates

Last Update Posted (Estimate)

December 14, 2022

Last Update Submitted That Met QC Criteria

December 12, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 201909036RINB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

The data that support the findings of this study will be available from the corresponding author upon reasonable request and approval of the research ethic committee.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critically Ill

Clinical Trials on Microcirculation examination

3
Subscribe